Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
advisory committee
Pharma
Zevra snags FDA approval for new lysosomal storage disorder med
The FDA has approved Zevra’s arimoclomol to treat the rare condition Niemann-Pick disease type C in conjunction with J&J's enzyme inhibitor miglustat.
Fraiser Kansteiner
Sep 20, 2024 1:54pm
FDA's ODAC calls for revamp of perioperative NSCLC trials
Jul 25, 2024 5:00pm
FDA review bodes well for MRD-based myeloma approvals
Apr 10, 2024 11:30am
FDA revokes approval of Oncopeptides' Pepaxto
Feb 23, 2024 11:10am
Sarepta's Elevidys expansion bid gets fast review without adcomm
Feb 16, 2024 11:05am
Amgen flunks Lumakras AdComm, but market pull looks unlikely
Oct 5, 2023 4:45pm